0001181431-13-025097.txt : 20130503 0001181431-13-025097.hdr.sgml : 20130503 20130503162856 ACCESSION NUMBER: 0001181431-13-025097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130502 FILED AS OF DATE: 20130503 DATE AS OF CHANGE: 20130503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REYNOLDS FRANCIS CENTRAL INDEX KEY: 0001503383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52089 FILM NUMBER: 13813024 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP. CENTRAL INDEX KEY: 0001292519 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-863-5524 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Design Source, Inc. DATE OF NAME CHANGE: 20040602 4 1 rrd378427.xml X0306 4 2013-05-02 0 0001292519 INVIVO THERAPEUTICS HOLDINGS CORP. NVIV 0001503383 REYNOLDS FRANCIS C/O INVIVO THERAPEUTICS HOLDINGS CORP. ONE KENDALL SQUARE, SUITE B14402 CAMBRIDGE MA 02139 1 1 1 0 CEO, CFO COMMON STOCK 2013-05-02 4 S 0 4250 3.06 D 13376560 D COMMON STOCK 2013-05-03 4 S 0 4250 3.01 D 13372310 D COMMON STOCK 19579 I By 401(k) plan The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.15, inclusive. The reporting person undertakes to provide InVivo Therapeutics Holdings Corp. ("InVivo"), any security holder of InVivo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.99 to $3.08 inclusive. /s/ Francis Reynolds 2013-05-03